NOMAD POWER SOLUTIONS, INC. Foreign Currency Transaction Gain (Loss), before Tax
NOMAD POWER SOLUTIONS, INC. (NMAD) reported Foreign Currency Transaction Gain (Loss), before Tax of $581 for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2025-08-07
- NOMAD POWER SOLUTIONS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-06-30 was $581.00, a 267.72% increase year-over-year.
- NOMAD POWER SOLUTIONS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-03-31 was $79.00.
- NOMAD POWER SOLUTIONS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2024-12-31 was -$284.00.
- NOMAD POWER SOLUTIONS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2024-09-30 was -$3.16K.
- NOMAD POWER SOLUTIONS, INC. foreign currency transaction gain (loss), before tax for fiscal 2024 was -$3.40K, a 274.16% decline from fiscal 2023.
- NOMAD POWER SOLUTIONS, INC. foreign currency transaction gain (loss), before tax for fiscal 2023 was $1.95K.
- NOMAD POWER SOLUTIONS, INC. foreign currency transaction gain (loss), before tax for fiscal 2022 was -$3.37K.
- NOMAD POWER SOLUTIONS, INC. foreign currency transaction gain (loss), before tax for fiscal 2021 was -$1.16K, a 230.67% decline from fiscal 2020.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|
| 2025-06-30 | $581.00 10-Q · filed 2025-08-07 | $660.00 10-Q · filed 2025-08-07 | $376.00 derived: sum of 3 quarters · filed 2025-08-07 | -$2.79K derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | $79.00 10-Q · filed 2025-05-12 | -$205.00 derived: sum of 2 quarters · filed 2025-05-12 | -$3.37K derived: sum of 3 quarters · filed 2025-05-12 | -$3.21K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-12-31 | -$284.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$3.44K derived: sum of 2 quarters · filed 2025-03-24 | -$3.29K derived: sum of 3 quarters · filed 2025-08-07 | -$3.40K 10-K · filed 2025-03-24 |
| 2024-09-30 | -$3.16K 10-Q · filed 2024-11-12 | -$3.00K derived: sum of 2 quarters · filed 2025-08-07 | -$3.12K 10-Q · filed 2024-11-12 | -$3.27K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-06-30 | $158.00 10-Q · filed 2025-08-07 | $42.00 10-Q · filed 2025-08-07 | -$106.00 derived: sum of 3 quarters · filed 2025-08-07 | -$215.00 derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$116.00 10-Q · filed 2025-05-12 | -$264.00 derived: sum of 2 quarters · filed 2025-05-12 | -$373.00 derived: sum of 3 quarters · filed 2025-05-12 | $504.00 derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | -$148.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$257.00 derived: sum of 2 quarters · filed 2025-03-24 | $620.00 derived: sum of 3 quarters · filed 2025-03-24 | $1.95K 10-K · filed 2025-03-24 |
| 2023-09-30 | -$109.00 10-Q · filed 2024-11-12 | $768.00 derived: sum of 2 quarters · filed 2024-11-12 | $2.10K 10-Q · filed 2024-11-12 | $67.00 derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $877.00 10-Q · filed 2024-08-08 | $2.21K 10-Q · filed 2024-08-08 | $176.00 derived: sum of 3 quarters · filed 2024-08-08 | -$1.12K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $1.33K 10-Q · filed 2024-05-09 | -$701.00 derived: sum of 2 quarters · filed 2024-05-09 | -$2.00K derived: sum of 3 quarters · filed 2024-05-09 | -$1.86K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$2.04K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | -$3.33K derived: sum of 2 quarters · filed 2024-03-19 | -$3.19K derived: sum of 3 quarters · filed 2024-03-19 | -$3.37K 10-K · filed 2024-03-19 |
| 2022-09-30 | -$1.30K 10-Q · filed 2023-11-09 | -$1.16K derived: sum of 2 quarters · filed 2023-11-09 | -$1.34K 10-Q · filed 2023-11-09 | -$1.42K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $142.00 10-Q · filed 2023-08-09 | -$39.00 10-Q · filed 2023-08-09 | -$120.00 derived: sum of 3 quarters · filed 2023-08-09 | -$1.28K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$181.00 10-Q · filed 2023-05-10 | -$262.00 derived: sum of 2 quarters · filed 2023-05-10 | -$1.43K derived: sum of 3 quarters · filed 2023-05-10 | -$1.33K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$81.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$1.25K derived: sum of 2 quarters · filed 2023-03-29 | -$1.15K derived: sum of 3 quarters · filed 2023-03-29 | -$1.16K 10-K · filed 2023-03-29 |
| 2021-09-30 | -$1.17K 10-Q · filed 2022-11-08 | -$1.07K derived: sum of 2 quarters · filed 2022-11-08 | -$1.08K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $94.00 10-Q · filed 2022-08-10 | $83.00 10-Q · filed 2022-08-10 | ||
| 2021-03-31 | -$11.00 10-Q · filed 2022-05-11 | |||
| 2020-12-31 | $890.00 10-K · filed 2022-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |